Skip to main content
Log in

Serum creatinine elevation caused by bupropion

  • letter to the editor
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs. 2000;59:1007–24.

    Article  CAS  PubMed  Google Scholar 

  2. Van Wyck Fleet J, Manberg PJ, Miller LL, et al. Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry. 1983;44:191–6.

    CAS  PubMed  Google Scholar 

  3. Uptodate.com. http://www.uptodate.com/contents/bupropion-drug-information. Accessed 26 May 2013.

  4. Laizure SC, DeVane CL, Stewart JT, et al. Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther. 1985;38:586–9.

    Article  CAS  PubMed  Google Scholar 

  5. Turpeinen M, Koivuviita N, Tolonen A, et al. Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites. Br J Clin Pharmacol. 2007;64:165–73.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Conflict of interest

The authors declare that there are no actual or potential conflicts of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mevlut Ceri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinalp, C., Kurultak, I., Ceri, M. et al. Serum creatinine elevation caused by bupropion. Wien Klin Wochenschr 126, 138–139 (2014). https://doi.org/10.1007/s00508-013-0466-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-013-0466-4

Keywords

Navigation